We are live on ! Find out more
HGEN

HUMANIGEN, INC.

Delisted

HGEN was delisted on the 25th of July, 2023.

3 hedge funds and large institutions have $509 invested in HUMANIGEN, INC. in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% less funds holding

Funds holding: 383 (-35)

100% less capital invested

Capital invested by funds: $841K → $509 (-$840K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 35

Holders
3
Holders Change
-35
Holders Change %
-92.11%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
35
Calls
Puts
Net Calls
Net Calls Change

HGEN Hedge Fund Activity: Q3 2023 in Review

3 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in HUMANIGEN, INC. (HGEN) for Q3 2023, worth a combined $509 — down 100% from $841K a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of HGEN and 0 opened new positions — a net loss of 35 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $261K sold.

  • 3 institutional investors held HUMANIGEN, INC. (HGEN) as of Q3 2023, down from 38 in Q2 2023.
  • Funds reported $509 of HUMANIGEN, INC. stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new HUMANIGEN, INC. positions in Q3 2023 and 35 closed out, a net change of -35 holders.
  • The largest HUMANIGEN, INC. seller in Q3 2023 was Vanguard Group, an estimated $261K sold.

Based on aggregated 13F filings for Q3 2023.